Clin2
NCT07873346Possibly a fitNot yet recruiting

Cholera vaccine study on gut health and bowel habits

Bowel HabitsGut MicrobiomesInflamatory Markers

This study tests an oral cholera vaccine to see how it affects your gut bacteria, inflammation, and bowel habits. Participation may help researchers understand how the vaccine works in real-world populations.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
200 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older and live in the local area.
  • You have no fever on the day you get the vaccine.
  • You have never had a cholera vaccine, or it has been at least 2 years since your last dose.
  • You are not currently sick with diarrhea or any other acute illness (within the last 7 days).
  • You have not taken antibiotics in the past 14 days and do not need to take them long-term.
  • You do not have severe health conditions like uncontrolled high blood pressure, serious heart/liver/kidney disease, or certain infections (like AIDS or active tuberculosis).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07300462Enrolling by invitation· Phase 4
Oral cholera vaccine safety study for children

This trial is for children aged 2 to 14 who have not had a cholera vaccine before. It tests a safe, oral vaccine to prevent cholera, a serious diarrheal disease.

Hefei, Anhui
NCT07304284Recruiting· Phase 3
Cholera vaccine study for healthy adults and people with HIV

This trial tests a new cholera vaccine (Biovac OCV-S) to see if it works as well as the current vaccine (Euvichol-Plus). It is for healthy people aged 1 to 45, and also for adults with HIV who are on treatment.

Durban, Eastern Cape
NCT06455852Recruiting
How well does the cholera vaccine protect you?

This study looks at how well the cholera vaccine and past infections protect people from getting cholera. It may help researchers understand who stays protected and for how long.

Dhaka
NCT07107516Recruiting· Phase 1
Testing an oral cholera vaccine in healthy adults

This study tests an oral cholera vaccine called PanChol in healthy adults. The goal is to see if it's safe and how the body responds. It may help protect against cholera, a serious diarrheal illness.

Lusaka, Lusaka Province
NCT07509047Recruiting· Phase 2
Cholera vaccine safety study for adults and children

This trial tests a new cholera vaccine in healthy people ages 1 to 45. It aims to see if the vaccine is safe and creates a good immune response.

Nairobi, Kenyatta National Hospital Complex
NCT07270796Not yet recruiting· Phase 1
Oral cholera vaccine safety study for healthy adults

This trial tests a new oral vaccine designed to protect against cholera. It is for healthy adults aged 18-45 who want to help evaluate the vaccine's safety and immune response. Participation involves receiving the vaccine and attending follow-up visits.

Stockholm

Hear when a new Bowel Habits trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.